Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis B Virus
Studies from F. Delahoz and colleagues yield new information about hepatitis B virus
April 30th, 2008
In this recently published study, investigators in Bogota, Colombia conducted a study "To evaluate the effectiveness of a recombinant hepatitis B vaccine used in endemic areas of Colombia, as well as risk factors associated with hepatitis B virus (HBV) infection and carriage after vaccine introduction. A cross-sectional study was carried out in urban and rural areas of the Colombian Amazon, a highly endemic area for hepatitis B infection." "Children under 12 years of age and their mothers were selected for the study using one-stage cluster sampling (N = 2145) and were examined for HBV serological markers and antibodies against surface antigen (anti-HBs). There has been...
Source: Vaccine Weekly (2008-04-30)
|
